拓新药业：关于完成变更独立董事的公告

Core Points - The company announced the convening of the second extraordinary general meeting of shareholders for 2025 on November 13, 2025, to review the proposal regarding the resignation of independent directors and the election of new independent directors [2] - The company approved the election of Dong Hongjie and Yang Dejie as independent directors of the fifth board of directors [2] - Dong Hongjie has completed the required training for independent directors organized by the Shenzhen Stock Exchange and received the training certificate [2]